Evidence map›Paper›PMID 28122514›Full record

ArticleBMC nephrology2017

Indoxyl sulfate - the uremic toxin linking hemostatic system disturbances with the prevalence of cardiovascular disease in patients with chronic kidney disease.

Tomasz W Kamiński, Krystyna Pawlak, Małgorzata Karbowska, Michał Myśliwiec, Dariusz Pawlak

Open access · goldAbstract read
In one paragraph

Article in BMC nephrology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 82 papers.

0numbers the graph read from it
0cells of the map it votes in
82citing papers in PubMed
6.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

82 citing papers in PubMed, 108 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Review
  5. pH regulates gut bacterial tryptophan metabolism.NPJ biofilms and microbiomes · 2026
    Article
  6. Article
  7. Raman signatures ofFrontiers in microbiology · 2026
    Article
  8. Review
  9. Unraveling the oral microbiome's role in Alzheimer's disease: From pathophysiology to therapeutic potential.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Gut microbial metabolism in Alzheimer's disease and related dementias.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2024
    Review
  20. Observational

22 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Tomasz W KamińskiDepartment of Pharmacodynamics, Medical University of Bialystok, Mickiewicza 2C Str., 15-222, Białystok, Poland.
Krystyna PawlakDepartment of Monitored Pharmacotherapy, Medical University of Bialystok, Mickiewicza 2C Str., 15-089, Białystok, Poland.
Małgorzata KarbowskaDepartment of Pharmacodynamics, Medical University of Bialystok, Mickiewicza 2C Str., 15-222, Białystok, Poland.
Michał MyśliwiecDepartment of Nephrology and Clinical Transplantation, Medical University of Bialystok, Żurawia 14 Str., 15-540, Bialystok, Poland.
Dariusz PawlakDepartment of Pharmacodynamics, Medical University of Bialystok, Mickiewicza 2C Str., 15-222, Białystok, Poland. dariuszpawlak@poczta.onet.pl.ORCID 0000-0002-3751-0608
Medical University of Białystok · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDuring chronic kidney disease progression, kidney-specific risk factors for cardiovascular disease come into play. The present study investigated the impact of indoxyl sulfate, dietary tryptophan-derived uremic toxin, accumulated in the blood of patients with chronic kidney disease on hemostatic parameters, markers of inflammation, oxidative stress and monocyte to macrophage transition.

methodsFifty-one CKD patients not undergoing hemodialysis were enrolled in the study. Coagulation factors, fibrinolytic parameters, adhesion molecules, endothelial dysfunction markers, oxidative stress as well as inflammation markers were examined using immune-enzymatic method. Indoxyl sulfate levels were assessed using high-performance liquid chromatography. Biochemical parameters were determined by routine laboratory techniques using an automated analyzers. All assessed parameters were compared with controls and subjected to cross-sectional statistical analysis.

resultsElevated concentrations of indoxyl sulfate, the vast majority of parameters affecting hemostasis, and markers of renal insufficiency conditions were observed. Part of hemostatic factors, namely tissue factor, von Willebrand factor, thrombomodulin, soluble urokinase-type plasminogen activator receptor, soluble intercellular adhesion molecule-1, soluble vascular cell adhesion protein were correlated with the fraction of indoxyl sulfate. A significant quantity of assessed parameters showed strong correlations with superoxide-dismutase, renal insufficiency rate, C-reactive protein, and neopterin. Levels of indoxyl sulfate were independently associated with markers of impaired endothelial function (thrombomodulin, adhesion molecules), oxidative stress (superoxide-dismutase) and monocytes activation determinant (neopterin), which indicate unconventional links between these systems and the role of indoxyl sulfate. Furthermore, parameters that correlated with the levels of indoxyl sulfate (von Willebrand factor, soluble urokinase-type plasminogen activator receptor, soluble intercellular adhesion molecule-1) were positively associated with the prevalence of cardiovascular disease in a CKD patients.

conclusionsThe study demonstrated that in conditions of chronic exposure to uremic toxins, indoxyl sulfate seems to be one of the "missing links" between impaired renal function and prevalence of cardiovascular events, especially hemostatic disorders. The main functions of the action appear to be altered monocytes activation, intensified inflammatory process, and augmented oxidative stress by this uremic toxin.

Indexed as

AdultAgedCardiovascular DiseasesCase-Control StudiesC-Reactive ProteinFemaleHemostasisHumansHydrogen PeroxideIndicanInflammationIntercellular Adhesion Molecule-1LipoproteinsMaleMiddle AgedNeopterinC-Reactive ProteinHydrogen PeroxideICAM1 protein, humanIndicanIntercellular Adhesion Molecule-1lipoprotein-associated coagulation inhibitorLipoproteinsNeopterinPeptide FragmentsPlasminogen Activator Inhibitor 1ProthrombinSERPINE1 protein, humanThrombinThromboplastinTissue Plasminogen ActivatorUrokinase-Type Plasminogen ActivatorVascular Cell Adhesion Molecule-1von Willebrand FactorCardiovascular diseaseChronic kidney diseaseHemostatic disorderIndoxyl sulfateMonocytes activationProthrombotic stateTissue factorTryptophan derivativesUremic toxinvon Willebrand factor

Identifiers

PMID28122514
PMCPMC5267373
OpenAlexW2581302565

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.